| New Antitrust Considerations for Tying Schemes |
The Intellectual Property Strategist |
2006 |
| You’re Not Exhausted: U.S. Patent Rights are Not Exhausted by Foreign Sales |
The Intellectual Property Strategist |
2005 |
| Interpreting Patent Claims |
Intellectual Property Strategist |
2004 |
| Chickens First or Eggs: Pre-Filing Commercialization Efforts |
Patent Strategy & Management |
2004 |
| Selecting the Right Forum for a Patent Dispute |
New York Law Journal |
2004 |
| Whether to Cancel National Trademark Registration In Favor of a CTM |
The Intellectual Property Strategist |
2003 |
| When Trust is Not Enough: The Duty to Investigate Before Filing |
Patent Strategy & Management |
2001 |
| Business Method Patents: Recent Developments in Examination, Legislation and Litigation |
International Legal Strategy |
2001 |
| The Amazon.com Case: Proof That Current Laws and Practice Are Adequate? |
The Intellectual Property Strategist |
2001 |
| Patents’ Effect on Trade Dress Protection |
Patent Strategy & Management |
2001 |
| A Look at Eli Lilly: When Must An Application disclose Unclaimed Subject Matter? |
The Intellectual Property Strategist |
2000 |
| Prozac Patents Satisfied Best Mode Where Omitted Material Was Known and Not Claimed |
Patent Strategy & Management |
2000 |
| Eight Pitfalls of Provisional Practice |
Patent Strategy & Management |
2000 |
| To Translate or Not to Translate, That is the Question |
The Intellectual Property Strategist |
2000 |
| Are States Now Immune from Patent and Trademark Infringement Suits? |
The Intellectual Property Strategist |
1999 |
| New Risk to Intellectual Property: Can States Infringe with Impunity? |
The Intellectual Property Strategist |
1999 |
| Enforcement of U.S. Patent Rights Through The International Trade Commission |
International Legal Strategy |
1999 |
| Utilitarian Objects: Why the Sum is Less Than the Parts |
The Intellectual Property Strategist |
1999 |
